XML 70 R56.htm IDEA: XBRL DOCUMENT v3.23.1

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Exercise Prices of Common Stock Options

Summary of Common Stock Options Exercisable

Stock		Number of Shares
Price		that Vest
$14.30			114,035
$22.00			151,522
$33.00			151,522
$44.00			151,522
			568,601

Schedule of Unrecognized Compensation Expense

Unrecognized compensation expense related to the stock-based compensation awards and equity-based awards as of December 31, 2022 was as follows:

Schedule of Unrecognized Compensation Expense 

		As of December 31, 2022
		Restricted Stock				Common Stock Options				ABG Warrants				Totals
Unrecognized compensation expense		$	13,515			$	17,369			$	1,006			$	31,890
Weighted average period expected to be recognized (in years)			1.53				1.62				1.00				1.56

Publisher Partner Warrant [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Exercise Prices of Common Stock Options

The exercise prices of the Publisher Partner Warrants outstanding and exercisable are as follows as of December 31, 2022.

Schedule of Exercise Prices of Common Stock Options 

Exercise		Outstanding				Exercisable
Price		(Shares)				(Shares)
$29.04 to $34.03			96				96
$34.04 to $39.03			1,247				1,247
$39.04 to $44.03			2,763				490
$44.04 to $49.50			48				48
			4,154				1,881

Schedule of Warrants Activity

A summary of the Publisher Partner Warrants activity during the year ended December 31, 2022 is as follows:

Schedule of Warrants Activity 

										Weighted
										Average
						Weighted				Remaining
		Number				Average				Contractual
		of				Exercise				Life
		Shares				Price				(in Years)
Publisher Partner Warrants outstanding at January 1, 2022			35,607			$	28.88				0.53
Expired			(31,453	)
Publisher Partner Warrants outstanding at December 31, 2022			4,154				38.81				0.09
Publisher Partner Warrants exercisable at December 31, 2022			1,881				37.06				0.19
Publisher Partner Warrants not vested at December 31, 2022			2,273
Publisher Partner Warrants available for future grants at December 31, 2022			86,756

ABG Warrants [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Exercise Prices of Common Stock Options

The exercise prices of the ABG Warrants outstanding and exercisable are as follows as of December 31, 2022.

Schedule of Exercise Prices of Common Stock Options 

Exercise				Outstanding				Exercisable
Price				(Shares)				(Shares)
$	9.24				749,655				299,862
$	18.48				249,885				99,954
					999,540				399,816

Schedule of Warrants Activity

A summary of the ABG Warrant activity during the year ended December 31, 2022 is as follows:

Schedule of Warrants Activity 

		Number of Shares								Weighted Average Exercise				Weighted Average Remaining Contractual Life
		Unvested				Vested				Price				(in years)
ABG Warrants outstanding at January 1, 2022			699,677				299,863			$	11.55				7.46
Vested			(99,953	)			99,953				10.39				-
ABG Warrants outstanding at December 31, 2022			599,724				399,816				11.55				6.46

Summary of Stock-based Compensation

Stock–based compensation and equity-based expense charged to operations or capitalized during the years ended December 31, 2022 and 2021 are summarized as follows:

Summary of Stock-based Compensation 

		Year Ended December 31, 2022
		Restricted Stock				Common Stock Options				ABG Warrants				Totals
Cost of revenue		$	3,730			$	6,505			$	-			$	10,235
Selling and marketing			270				2,502				-				2,772
General and administrative			9,067				7,776				1,495				18,338
Total costs charged to operations			13,067				16,783				1,495				31,345
Capitalized platform development			-				1,884				-				1,884
Total stock-based compensation		$	13,067			$	18,667			$	1,495			$	33,229

		Year Ended December 31, 2021
		Restricted Stock				Common Stock Options				ABG Warrants				Totals
Cost of revenue		$	999			$	6,479			$	-			$	7,478
Selling and marketing			2,118				3,258				-				5,376
General and administrative			8,953				6,870				1,816				17,639
Total costs charged to operations			12,070				16,607				1,816				30,493
Capitalized platform development			54				1,991				-				2,045
Total stock-based compensation		$	12,124			$	18,598			$	1,816			$	32,538

Restricted Stock Units [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Restricted Stock Units Activity

A summary of the restricted stock unit activity during the year ended December 31, 2022 is as follows:

Schedule of Restricted Stock Units Activity 

		Number of Shares								Weighted Average Grant-Date
		Unvested				Vested				Fair Value
Restricted stock units outstanding at January 1, 2022			1,636,111				155,211			$	14.93
Granted			442,145				-				11.35
Vested			(1,074,398	)			1,074,398				-
Released			-				(832,233	)			-
Cancelled			(9,092	)			-				-
Restricted stock units outstanding at December 31, 2022			994,766				397,376				15.44

Common Equity Awards [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Fair Value of Stock Options Assumptions

Schedule of Fair Value of Stock Options Assumptions 

		Years Ended December 31,
		2022								2021
		Up-list				No Up-list				Up-list				No Up-list
Risk-free interest rate			0.97% - 4.36	%			0.97% - 1.44	%			0.16% - 1.48	%			0.16% - 1.48	%
Expected dividend yield			0.00	%			0.00	%			0.00	%			0.00	%
Expected volatility			42.00% - 82.00	%			82.00% - 137.00	%			65.00% - 90.00	%			133.00% - 140.00	%
Expected life			3.0 – 6.0 years				3.0 – 6.0 years				3.0 – 6.0 years				3.0 – 6.0 years

Summary of Stock Option Activity

A summary of the common stock option activity during the year ended December 31, 2022 is as follows:

Summary of Stock Option Activity 

										Weighted
										Average
						Weighted				Remaining
		Number				Average				Contractual
		of				Exercise				Life
		Shares				Price				(in Years)
Common stock options outstanding at January 1, 2022			5,525,395			$	15.26				8.20
Granted			1,370,217				10.64
Exercised			(341,113	)			8.79
Forfeited			(234,963	)			13.91
Expired			(120,015	)			12.34
Common stock options outstanding at December 31, 2022			6,199,521				9.73				7.61
Common stock options exercisable at December 31, 2022			3,444,261				9.55				7.00
Common stock options not vested at December 31, 2022			2,755,260
Common stock options available for future grants at December 31, 2022 (1)			504,782

(1) Shares of the Company’s common stock available for future grants under the 2022 Plan represent 1,800,000 shares authorized less an aggregate of 964,455 common stock options outstanding and 330,763 restricted stock units outstanding.

Common Stock Awards [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Exercise Prices of Common Stock Options

The exercise prices under the common stock options outstanding and exercisable are as follows as of December 31, 2022:

Schedule of Exercise Prices of Common Stock Options 

Exercise		Outstanding				Vested
Price		(Shares)				(Shares)
$3.74 to $10.50			4,879,580				3,167,307
$10.51 to $15.52			1,239,913				201,976
$15.53 to $20.54			11,270				10,765
$20.55 to $25.56			26,365				21,820
$25.57 to $30.58			1,251				1,251
$30.59 to $35.60			6,366				6,366
$35.61 to $40.62			2,728				2,728
$40.63 to $48.40			32,048				32,048
			6,199,521				3,444,261

X

- Definition

Schedule Of Restricted Stock Units Activity [Table Text Block]

+ References

No definition available.

+ Details

Name:	AREN_ScheduleOfRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	AREN_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule Of Unrecognized Compensation Expense [Table Text Block]

+ References

No definition available.

+ Details

Name:	AREN_ScheduleOfUnrecognizedCompensationExpense
Namespace Prefix:	AREN_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule Of Warrants Activity [Table Text Block]

+ References

No definition available.

+ Details

Name:	AREN_ScheduleOfWarrantsActivityTableTextBlock
Namespace Prefix:	AREN_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_PlanNameAxis=AREN_PublisherPartnerWarrantProgramMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=AREN_ABGWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=AREN_RestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=AREN_CommonEquityAwardsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=AREN_CommonStockAwardsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: